Integrated Wealth Concepts LLC Increases Stake in Agilent Technologies, Inc. (NYSE:A)

Integrated Wealth Concepts LLC boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 24.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,413 shares of the medical research company’s stock after buying an additional 671 shares during the quarter. Integrated Wealth Concepts LLC’s holdings in Agilent Technologies were worth $458,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its stake in shares of Agilent Technologies by 0.6% in the fourth quarter. Wellington Management Group LLP now owns 9,306,805 shares of the medical research company’s stock valued at $1,250,276,000 after acquiring an additional 59,781 shares in the last quarter. Geode Capital Management LLC increased its holdings in Agilent Technologies by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company’s stock worth $938,291,000 after purchasing an additional 53,992 shares during the period. Pictet Asset Management Holding SA raised its position in Agilent Technologies by 0.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 5,213,739 shares of the medical research company’s stock valued at $700,414,000 after purchasing an additional 47,495 shares in the last quarter. Norges Bank purchased a new position in shares of Agilent Technologies in the 4th quarter valued at about $456,963,000. Finally, Cantillon Capital Management LLC grew its position in shares of Agilent Technologies by 0.5% during the fourth quarter. Cantillon Capital Management LLC now owns 3,316,557 shares of the medical research company’s stock worth $445,546,000 after buying an additional 17,627 shares in the last quarter.

Analysts Set New Price Targets

A has been the subject of a number of recent research reports. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating for the company in a research note on Thursday, April 17th. Jefferies Financial Group lowered their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating for the company in a research note on Monday, April 21st. Robert W. Baird cut their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. TD Cowen increased their price objective on Agilent Technologies to $135.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Finally, Barclays cut their target price on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $143.00.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $108.68 on Friday. The stock has a market capitalization of $30.98 billion, a price-to-earnings ratio of 24.98, a PEG ratio of 3.03 and a beta of 1.27. The firm’s fifty day simple moving average is $113.57 and its 200-day simple moving average is $129.83. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were paid a $0.248 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.91%. Agilent Technologies’s payout ratio is 22.76%.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the transaction, the director now directly owns 35,737 shares of the company’s stock, valued at $4,161,931.02. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.